Mevinolin (MK803), a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCoA reductase) (K;, 30 x 10-9 M), depressed de novo synthesis of cholesterol in 11-day chicken embryonic cardiac cells cultured in lipoprotein-deficient serum (LPDS). Cardiac cells exposed to different concentrations of mevinolin for 1-3 days presented different electrophysiological and mechanical properties: (i) The resting membrane potential, the rate of increase, and the shape of the action potential and contractile properties were changed at concentrations as low as 0.1 ,.M mevinolin. (ii) At a concentration of 1 ,iM mevinolin, the cardiac cells became quiescent and electrical stimulation induced action potentials of short duration without contraction. Isoproterenol and Bay K8644 were unable to restore excitability and contraction.
channel blocker nitrendipine was the same in control and in mevinolin-treated cells, voltage-clamp data on isolated cardiac cells and 45Ca2+ flux experiments on monolayers showed that most of the slow Ca2+ channel activity was lost in mevinolintreated cells. These results suggest that the disappearance of Ca2+ channel activity is most probably at the origin of the loss of cardiac contractility.
All mammalian cells require free cholesterol both for biogenesis and for the function of their plasma membrane. This cholesterol is acquired from the exogenous source constituted by the low density lipoprotein fraction of lipoproteins (1, 2) . It also comes from de novo synthesis within the cell (3) . Previous work with chicken cardiac cells in culture has shown that cells cultivated in low density lipoprotein-free medium had a changed level of cholesterol in their plasma membrane, which was accompanied by changes in electrical properties (4) .
This work analyzes the effect of mevinolin on excitability and contraction of cardiac cells in culture. Mevinolin (MK803) is a natural product of fungal origin that acts as an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) (5) (6) (7) . This enzyme catalyzes the conversion of hydroxymethylglutamate to mevalonate, which is the first and rate-limiting step in the cholesterol biosynthesis pathway (8) . Mevinolin lowers serum cholesterol in dog (5, 9) , in the normal human (10) , and in hypercholesterolemic patients (11, 12) . This molecule has been suggested as being a potentially useful drug in the treatment of hypercholesterolemia (5) .
MATERIALS AND METHODS
Heart Cell Cultures. Ventricular cells from 11-day-old chicken embryos were dissociated by trypsinization as described (13) . Cells were either cultured in the form of monolayers or as isolated cells. The standard medium used was supplemented with 5% lipoprotein-deficient serum (LPDS). Mevinolin was added every 12 hr for 1-3 days at concentrations ranging between 10 nM and 10 ,uM, 2 days after plating.
Concentrations of mevinolin between 10 nM and 0.1 AM produced no apparent change in the cell morphology even after 3 days of treatment. For higher concentrations, between 1 AM and 10 ,uM, mevinolin caused morphological changes of cardiac cells. Cells had a tendency to retract from neighboring and to round up. Cell death often occurred after 4 days when treated with 10 ,uM mevinolin.
Preparation of LPDS. LPDS was prepared as described (4) using fetal calf serum (Seromed, Munich, F.R.G.), adjusted to a density of 1.21 by addition of solid KBr, and centrifuged twice to remove all lipoproteins.
Cholesterol Determination. The amount of cholesterol in cultured embryonic cardiac cells was measured after extraction of lipids in chloroform/methanol (2:1, vol/vol), according to Bligh and Dyer (14) . Total cholesterol was determined according to Ott et al. (15 Measurement of HMG-CoA Reductase Activity. Measurements of HMG-CoA reductase activity were carried out as described (17) . Cardiac cells were exposed to mevinolin for 2 days before measurement.
ATP Determination. ATP content in cardiac cells cultured either in the presence or in the absence of mevinolin was determined with a commercial enzymatic assay (Sigma). Binding Assays. Biochemical titrations of the Na+ channel were carried out as described (4) using homogenates prepared from chicken heart cells in culture and tritiated ethylenediamine tetrodotoxin ([3H]en-TTX) (20) . Biochemical titrations of the Ca2+ channel were carried out using tritiated nitrendipine as described (21) . 22Na' and 45Ca2' Flux Experiments. Rates of 22Na' uptake by cardiac cells in culture were determined as described (22) . The preincubation medium was supplemented with 0.5 mM ouabain to inhibit the Na+,K+-ATPase and with veratridine (0.2 mM) and sea anemone toxin II (10 uM) to activate the Na+ channel.
Determinations of nitrendipine-sensitive and insensitive rates of 45Ca2+ uptake were made in the presence or absence of the Ca2W channel agonist Bay K8644 as described (23) . produced a decrease in the total cholesterol content of the cells as indicated in Table 1 .
RESULTS

Chicken embryonic heart cells have been cultured in LPDS
Mevinolin had no effect on the internal level of ATP at concentrations ranging from 0.1 nM to 1 ,M. This level remained constant at a value of 27 ± 2 nmol of ATP per mg of protein after 2 days of treatment.
Electrical and Contractile Activities of Chicken Embryonic Cardiac Cells in the Presence and in the Absence of Mevinolin. Fig. 1 shows that control cardiac cells grown in LPDS in the absence of mevinolin had a maximal diastolic potential of -75 mV and a maximum upstroke velocity (Vmax) of the action potential (AP) of 120 V/sec (Fig. 1A) . Cells treated with 0.1 ,uM mevinolin were less polarized (-45 ± 5 mV) than control cells and their contractility was slightly depressed (Fig. 1B) . After a 2-day treatment with 1 ,M mevinolin, spontaneous electrical activity and beating were suppressed. Electrically evoked APs could be generated after prepolarization (Fig. 1C ), but they did not produce contractions.
Maximal diastolic potentials, Vma values, and cholesterol levels at different mevinolin concentrations are summarized in Table 1 .
Sensitivities to TTX and isoproterenol of control and mevinolin-treated cardiac cells are presented in Fig. 2A . TTX (0.1 AM) suppressed the AP and blocked spontaneous beating in control cells ( Fig. 2A, traces a and b) . Under these conditions, isoproterenol (1 ,LM) restored both excitability and contraction ( Fig. 2A, trace c) . Addition of 10 nM nitrendipine drastically depressed the slow AP duration and blocked contraction as previously observed (21) . In mevinolin-treated cardiac cells, TTX suppressed the evoked AP ( Fig. 2A , traces d and e) and addition of isoproterenol after TTX blockade of Na' channels ( Fig. 2A , trace f) was unable to restore excitability and contraction. Fig. 2B shows that Bay K8644 produced marked effects on both duration of the AP and contraction when added to control cardiac cells (Fig. 2B, traces a and b) . Conversely, the electrically induced AP in mevinolin-treated cells (Fig. 2B , trace c) remained unchanged in the presence of 10 nM Bay K8644. Under these conditions, Bay K8644 did not restore contraction (Fig. 2B, trace d) .
The voltage dependence of the Ca2l current of isolated cardiac cells was similar to that found in other types of cardiac cells (24) (25) (26) (27) (28) . The threshold was observed at about -40 mV and the maximum inward current was between 0 and +10 mV (Fig. 3A) The pharmacological properties of the slow Ca2W channel were similar to those of cardiac Ca2W channels from different animal origins (23) (24) (25) (26) (27) (28) . Peak Ca2+ current amplitude increased after external application of isoproterenol (1 uM) (Fig. 3B) and of Bay K8644 (10 nM) (Fig. 3C) . Fig. 3A shows that the Ca2+ current was strongly depressed in mevinolin- treated cardiac cells. However, Ca2l channel blockers had the same blocking potencies on the decreased Ca2+ current as on nontreated cardiac cells (not shown). Conversely, mevinolintreated cells had Ca2+ channels that were much less sensitive to isoproterenol (Fig. 3B) or Bay K8644 (Fig. 30 than control cells. Both drugs produced a mean increase of Ca2`current of only -15%, as compared to 50% in control cells.
Biochemical Investigations of the Properties of Voltage-
Dependent Na+ and Ca2+ Channels in Control and MevinolinTreated Cardiac Cells. Veratridine and sea anemone toxin II are specific for the gating system of the Na+ channel (29) . These two toxins are synergistic in their action and increase the rate of 22Na+ entry through voltage-sensitive Na+ channels of cardiac cells. Fig. 4 shows that the 22Na+ uptake component that can be activated by the mixture of veratridine plus toxin II and inhibited by 0.1 ,uM TTX with a halfmaximum effect at 4 nM is identical in both mevinolin-treated and nontreated cells (Fig. 4 Inset A) .
Maximum binding capacities (Bmt) and dissociation constants (Kd) for the [3H]en-TTX-receptor complex were 38 + 5 fmol per mg of protein and 1.3 ± 0.3 nM for control and 40 ± 4 fmol per mg of protein and 1.2 ± 0.2 nM for mevinolintreated cells (Fig. 4 K+ medium, their membrane potential was at -75 mV (Table  1) . Under these conditions, 45Ca2+ uptake was not affected by nitrendipine (Fig. 5 Inset A) . Addition of 10 nM Bay K8644 increased (2-fold) the initial rate of 45Ca2+ uptake in nontreated cells (Fig. 5 ). This component of 45Ca2' uptake was blocked by nitrendipine. When cells were incubated in a high K+ medium, they were depolarized to -30 ± uptake (3.5-fold) in nontreated cells (Fig. 5 Inset A) . This increased uptake was inhibited by 1 ,uM nitrendipine. When cardiac cells were treated by 1 ,M mevinolin, the rate of 45Ca2+ uptake was neither affected by addition of Bay K8644 or nitrendipine (Fig. 5 ) in polarized conditions (5 mM K+), nor by depolarization (40 mM K+). Fig. 5 shows that isoproterenol (10 ,iM) increased the component of 45Ca2+ uptake induced by depolarization in control cells and that this increase was inhibited by 1 ,M nitrendipine. Conversely, in mevinolin-treated cells isoproterenol did not increase 45Ca2+ uptake observed in depolarized conditions (Fig. 5) . Bm,, and Kd values of the [3H]nitrendipine-receptor complex were 120 ± 10 fmol per mg of protein and 0.5 ± 0.1 nM for control and 100 ± 10 fmol per mg of protein and 0.4 ± 0.1 nM for mevinolin-treated cardiac cells (Fig. 5 Inset B) .
DISCUSSION
Uptake, storage, and synthesis of cholesterol by cells is regulated by low and high density lipoproteins (1, 2) . Previous work from this laboratory has shown that cardiac cells from 11-day chicken hearts had different electrophysiological properties when they were cultured in medium supplemented with fetal calf serum or with LPDS (4). These observations and those of others (30), who had treated heart myocytes with a mixture of high-density lipoproteins and sphingomyelin to deplete the cells of cholesterol, suggested that the cholesterol level in the plasma membrane was crucially involved in the control of excitability of cardiac cells.
The approach taken in this paper has been to analyze, using chicken cardiac cells cultivated in LPDS, the effects of mevinolin, a potent inhibitor of cholesterol biosynthesis, which is a potential new drug for the treatment of hypercholesterolemia (5) (6) (7) (8) .
Mevinolin content in cardiac cells. At 0.1 ,.M mevinolin, the total cholesterol content was 26% lower than in nontreated cells.
Mevinolin concentration of 0.1 ttM produced very significant effects on the maximal diastolic potential, the Vmax of the AP, and the contractility of heart cells ( Table 1) . Changes in electrophysiological properties were not linked to variations of internal ATP concentration. Effects of mevinolin pretreatment on the resting potential may be due to an alteration of a K+ conductance and/or of a change in the catalytic properties of the Na',K+-ATPase.
The most striking effect of mevinolin treatment (Figs. 1 and  2) is the tendency to uncouple excitation from contraction.
Mammalian cardiac cells have both slow and fast Ca2' channels (26, 27) . Fast Ca2`channels do not seem to be expressed in the embryonic chicken heart cell. Slow channels are known to be essential in excitation-contraction coupling in cardiac cells (31) (32) (33) . Therefore, particular attention has been paid to these channels. The activity of the voltagedependent slow Ca2+ channel in cardiac cells can be increased in two ways: (i) by isoproterenol treatment, which acts via cyclic AMP and phosphorylation of the channel protein (32-34); (ii) by treatment with the Ca2+ channel agonist Bay K8644, which activates 45Ca2+ uptake and increases the peak Ca2' current (24) (25) (26) (27) (28) . Both treatments clearly increased Ca2+ channel activity in control chicken heart cells (Fig. 2) . Isoproterenol produced a slow Ca2' AP in cells that had been treated with TTX to suppress the fast Na' component of the AP. Under these conditions, isoproterenol triggered strong contractions. Bay K8644 prolonged the plateau phase of the AP and had cardiotonic effects (Fig. 2B) channel activity is most probably at the origin of the loss of cardiac contractility.
The effects of mevinolin on heart-cell excitability and contractility in the whole animal or in humans are difficult to evaluate from this work. Animals treated by mevinolin will of course have a partial inhibition of endogenous cholesterol synthesis in all tissues, but they will also be in a situation in which the low density lipoprotein fractions of lipoproteins will still provide exogenous cholesterol to cardiac cells. Therefore, the effects of mevinolin in animals or in humans will certainly be much less drastic than those observed here with cardiac cells cultured in low density lipoprotein-free medium and in higher concentrations of the drug.
